Your browser doesn't support javascript.
loading
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
Tupone, Maria Grazia; D'Aguanno, Simona; Di Martile, Marta; Valentini, Elisabetta; Desideri, Marianna; Trisciuoglio, Daniela; Donzelli, Sara; Sacconi, Andrea; Buglioni, Simonetta; Ercolani, Cristiana; Biagioni, Alessio; Fibbi, Gabriella; Fattore, Luigi; Mancini, Rita; Ciliberto, Gennaro; Blandino, Giovanni; Del Bufalo, Donatella.
Afiliação
  • Tupone MG; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • D'Aguanno S; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Di Martile M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Valentini E; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Desideri M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Trisciuoglio D; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Donzelli S; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Sacconi A; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
  • Buglioni S; Oncogenomics and Epigenetics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ercolani C; Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Biagioni A; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Fibbi G; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Fattore L; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Mancini R; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Ciliberto G; Department of Melanoma, Oncologic Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori IRCCS, "Fondazione G. Pascale", Naples, Italy.
  • Blandino G; Department of Molecular and Clinical Medicine, Risk Management Q&A, Sant'Andrea Hospital, "Sapienza" University, Rome, Italy.
  • Del Bufalo D; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Oncogenesis ; 9(2): 22, 2020 Feb 14.
Article em En | MEDLINE | ID: mdl-32060259
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogenesis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogenesis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália